 |
Press
Releases
|
August 26, 1998 - Trinity Biotech Asserts
Patent Rights
August 26, 1998 - Trinity files patent
complaints
August 5, 1998 - Trinity Biotech Receives
FDA Clearance of Two Additional Infectious Disease Markers
July 22, 1998 - Trinity Biotech Announces
119% Increase in Second Quarter Profits
July 21, 1998 - Trinity Biotech Files 510k
With FDA for One Step Uni-Gold Strep A Test
July 8, 1998 - Trinity Biotech Announces
Acquisition of Hormone and Drugs of Abuse Range of Diagnostic Tests
July 8, 1998 - Trinity Biotech Extends
Class B Warrants
July 8, 1998 - Trinity Biotech cuts warrant
price, extends life
June 1, 1998 - Trinity Biotech Receives FDA
Clearance of Two Infectious Disease Markers
June 1, 1998 - Trinity Biotech says FDA clears
product
May 5, 1998 - Trinity Biotech
Announces Record Breaking First Quarter Profits.
May 5, 1998 - Trinity Biotech
Retains OTC Communications to Lead Comprehensive Investor Relations Campaign.
May 5, 1998 - Trinity Biotech plc
Posts 1Q $0.02 vs $0.01.
March 19, 1998 - Trinity Biotech
Directors Purchase Shares in the Company.
March 10, 1998 - Trinity Biotech Expands
Manufacturing Capacity, Receives Grant From Irish Government.
March 6, 1998 - Trinity Biotech Posts $0.02 4Q
EPS vs. $0.05 Loss.
March 5, 1998 - Trinity Biotech Reports Record
1997 Year End Results.
February 26, 1998 - Trinity Biotech Distributor
Wins Government HIV Screening Tender in Malaysia.
February 18, 1998 - Trinity Biotech Announces
Launch Of Uni-Gold H. Pylori Test.
January 20, 1998 - Trinity Biotech plc Launches
Uni-Gold(TM) HIV With Smithkline Beecham.
January 7, 1998 - Trinity Biotech Gets FDA
Okay to Market Adenovirus Test Kit.
January 7, 1998 -Trinity Biotech Receives FDA
Clearance On Adenovirus Test Kit.
July 8, 1997 -Trinity Biotech Announces
Acquisition of Centocor's U.K. Infectious Disease Business
June 18, 1997 - Trinity Biotech Announces
Cancer Diagnostics
Agreement with Centocor Inc.
June 4, 1997 - Trinity Biotech Commences Sales
of Five Newly FDA - Approved Products.
April 30, 1997 - Trinity Biotech Awarded $600,000 by the Irish Trade Board.
February 24, 1997 - Trinity Biotech Acquires Clark Laboratories.
January 28, 1997 - Trinity Biotech Signs
Agreement with Calypte Biomedical Corporation to Develop Urine Based HIV Test.
November 18, 1996 - Trinity Biotech Signs
Licence Agreement with Imperial College London.
November 4, 1996 - Trinity Biotech Announces
Second Profitable Quarter.
October 29, 1996 - Trinity Biotech Announces
Consolidation of R & D and Opening of a New US Marketing Office.
August 12, 1996 -
Trinity Biotech Announces First Profitable Quarter.
July 30, 1996 - Trinity Biotech Launches One-Step
HIV and Hepatitis Tests.
|
|